Amantadine withdrawal and neuroleptic malignant syndrome.
Weller
M
M
Kornhuber
J
J
D000547:Amantadine / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome; D010300:Parkinson Disease / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome
D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine